Toledo, Ohio 43606

  • Migraine Headache


This study will measure two types of markers, adipokines and cytokines during an acute migraine attack. Adipokines have not previously been studied in this manner. Measurements of these markers in treated and untreated patients during an acute migraine attack ang again at a pain free interval may lead to increased understanding of the pathway to neurologic inflammation giving rise to migraine.


Inclusion Criteria: - >= 18 years old - Migraine diagnosis with frequency of at least 1 per month with a severity of moderate or greater (determined by headache diary for 30 days after screening visit) Exclusion Criteria: - Inflammatory, autoimmune or infectious diseases - Chronic pain other than headache - Pregnancy (by self report at screening and by negative urine pregnancy test in woman of childbearing potential prior to treatment) - Change in migraine prophylaxis 1 month prior to screening and until the final visit is completed - Metabolic, thyroid, renal, cardiovascular and gastrointestinal diseases - Allergy to a triptan or non-steroidal medication - Contraindication to the use of a triptan of non-steroidal medication



Primary Contact:

Principal Investigator
Gretchen Tietjen, MD
University of Toledo Health Science Campus

Gretchen Teitjen, MD
Phone: 419-383-6087

Backup Contact:


Location Contact:

Toledo, Ohio 43606
United States

Gretchen Teitjen, MD
Phone: 419-383-6087

Site Status: Recruiting

Data Source:

Date Processed: October 02, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.